Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Siglec-6

Siglec-6

Brief Information

Name:Sialic acid-binding Ig-like lectin 6
Target Synonym:CD33 antigen-like 1,CDw327,Obesity-binding protein 1 (OB-BP1),OBBP1,CD33L,CD33L1,CD327
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
SI6-H5256 Human Human Siglec-6 / CD327 Protein, Fc Tag
SI6-H5256-structure
SI6-H5256-sds
ACRO Quality

Part of Bioactivity data

SI6-H5256-ELISA
 Siglec-6 ELISA

Immobilized Human Siglec-6, Fc Tag (Cat. No. SI6-H5256) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human Siglec-6 Antibody, Rabbit IgG with a linear range of 0.2-16 ng/mL (QC tested).

Customer Reviews

Synonym Name

SIGLEC6,CD327,CD33L,CD33L1,OBBP1,OB-BP1,CDw327

Background

Sialic acid-binding Ig-like lectin 6 (SIGLEC6) is also known as CD antigen CD327, CD33 antigen-like 1 (CD33L or CD33L1), Obesity-binding protein 1 (OB-BP1). SIGLEC6 belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family, which contains two Ig-like C2-type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. SIGLEC6 mediates sialic-acid dependent binding to cells. SIGLEC6 binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
anti-siglec-6 CAR-T cell therapy(Xuzhou Medical University) Phase 2 Clinical Xuzhou Medical University (Xzmu) Leukemia, Myeloid, Acute Details
AK-006 AK006 Phase 1 Clinical Allakos Inc Chronic Urticaria; Inflammation Details
anti-siglec-6 CAR-T cell therapy(Xuzhou Medical University) Phase 2 Clinical Xuzhou Medical University (Xzmu) Leukemia, Myeloid, Acute Details
AK-006 AK006 Phase 1 Clinical Allakos Inc Chronic Urticaria; Inflammation Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message